{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:19:09Z","timestamp":1789096749201,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,16]]},"DOI":"10.7759\/cureus.11509","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T17:20:17Z","timestamp":1605547217000},"source":"Crossref","is-referenced-by-count":18,"title":["Neurological Manifestations of Wilson's Disease: Pathophysiology and Localization of Each Component"],"prefix":"10.7759","author":[{"given":"Juan Fernando","family":"Ortiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Morillo Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willians","family":"Tambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Eskander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Valdez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ni\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60196-2","article-title":"Wilson\u2019s disease","volume":"369","author":"Ala A","year":"2007","unstructured":"Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson\u2019s disease. Lancet. 2007, 369:397-408. 10.1016\/S0140-6736(07)60196-2","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0018-3","article-title":"Wilson disease","volume":"4","author":"Cz\u0142onkowska A","year":"2018","unstructured":"Cz\u0142onkowska A, Litwin T, Dusek P, et al.. Wilson disease. Nat Rev Dis Primers. 2018, 4:1-20. 10.1038\/s41572-018-0018-3","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.05109.x","article-title":"Neurologic Wilson\u2019s disease","volume":"1184","author":"Lorincz MT","year":"2010","unstructured":"Lorincz MT. Neurologic Wilson\u2019s disease. Ann N Y Acad Sci. 2010, 1184:173-87. 10.1111\/j.1749-6632.2009.05109.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1002\/mds.21170","article-title":"Neurological manifestations in Wilson\u2019s disease: report of 119 cases","volume":"21","author":"Machado A","year":"2006","unstructured":"Machado A, Chien HF, Deguti MM,  Can\u00e7ado E, Azevedo RS, Scaff M,  Barbosa ER. Neurological manifestations in Wilson\u2019s disease: report of 119 cases. Mov Disord. 2006, 21:2192-2196.","journal-title":"Mov Disord"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-60189-2_16","article-title":"Neurotoxicity of copper","author":"Bulcke F","year":"2017","unstructured":"Bulcke F, Dringen R, Scheiber IF. Neurotoxicity of copper. Advances in Neurobiology. Aschner M., Costa L. (ed): Springer International Publishing, Cham; 2017. 18:313-343. 10.1007\/978-3-319-60189-2_16"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2016.327","article-title":"Coexisting Parkinson\u2019s and Wilson\u2019s disease: chance or connection?","volume":"44","author":"Gasca-Salas C","year":"2017","unstructured":"Gasca-Salas C, Alonso A, Gonz\u00e1lez-Redondo R, Obeso JA. Coexisting Parkinson\u2019s and Wilson\u2019s disease: chance or connection?. Can J Neurol Sci. 2017, 44:215-8. 10.1017\/cjn.2016.327","journal-title":"Can J Neurol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1585097","article-title":"Parkinsonism","volume":"36","author":"Keener AM","year":"2016","unstructured":"Keener AM, Bordelon YM. Parkinsonism. Semin Neurol. 2016, 36:330-4. 10.1055\/s-0036-1585097","journal-title":"Semin Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5255-7","article-title":"Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study","volume":"257","author":"Colosimo C","year":"2009","unstructured":"Colosimo C, Morgante L, Antonini A, et al.. Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. J Neurol. 2009, 257:5. 10.1007\/s00415-009-5255-7","journal-title":"J Neurol"},{"key":"ref9","article-title":"Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease","volume":"24","author":"Barthel H","year":"2003","unstructured":"Barthel H, Hermann W, Kluge R, Hesse S, Collingridge DR, Wagner A, Sabri O. Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease. Am J Neuroradiol. 2003, 24:234-8.","journal-title":"Am J Neuroradiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2014.05.007","article-title":"The neurotoxicity of iron, copper and manganese in Parkinson\u2019s and Wilson\u2019s diseases","volume":"31","author":"Dusek P","year":"2015","unstructured":"Dusek P, Roos PM, Litwin T, Schneiderf SA, Flateng TA, Aasethh J. The neurotoxicity of iron, copper and manganese in Parkinson\u2019s and Wilson\u2019s diseases. J Trace Elem Med Biol. 2015, 31:193-203. 10.1016\/j.jtemb.2014.05.007","journal-title":"J Trace Elem Med Biol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/BF00920620","article-title":"Dopamine D2 receptor binding and cerebral glucose metabolism recover after D-penicillamine-therapy in Wilson\u2019s disease","volume":"241","author":"Schlaug G","year":"1994","unstructured":"Schlaug G, Hefter H, Nebeling B, et al.. Dopamine D2 receptor binding and cerebral glucose metabolism recover after D-penicillamine-therapy in Wilson\u2019s disease. J Neurol. 1994, 241:577-84. 10.1007\/BF00920620","journal-title":"J Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-019-01065-x","article-title":"The working life of people with degenerative cerebellar ataxia","volume":"18","author":"Ranavolo A","year":"2019","unstructured":"Ranavolo A, Serrao M, Varrecchia T, et al.. The working life of people with degenerative cerebellar ataxia. Cerebellum. 2019, 18:910-21. 10.1007\/s12311-019-01065-x","journal-title":"Cerebellum"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-63625-6.00005-7","article-title":"Chapter 5 - Pathogenesis of Wilson disease","author":"Scheiber IF","year":"2017","unstructured":"Scheiber IF, Br\u016fha R, Du\u0161ek P. Chapter 5 - Pathogenesis of Wilson disease. Handbook of Clinical Neurology. Hetts S, Cooke D (ed): Elsevier, Amsterdam, Netherlands; 2017.  142:43-55. 10.1016\/B978-0-444-63625-6.00005-7"},{"key":"ref14","article-title":"Chapter 10 - Wilson disease: neurologic features","author":"Cz\u0142onkowska A","year":"2017","unstructured":"Cz\u0142onkowska A, Litwin T, Chabik G. Chapter 10 - Wilson disease: neurologic features. Handbook of Clinical Neurology. Cz\u0142onkowska A, Schilsky ML (ed): Elsevier, Amsterdam, Netherlands; 2017. 1016:978-80."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2018.10.096","article-title":"A study of brain MRI characteristics and clinical features in 76 cases of Wilson\u2019s disease","volume":"59","author":"Zhong W","year":"2019","unstructured":"Zhong W, Huang Z, Tang X. A study of brain MRI characteristics and clinical features in 76 cases of Wilson\u2019s disease. J Clin Neurosci. 2019, 59:167-74. 10.1016\/j.jocn.2018.10.096","journal-title":"J Clin Neurosci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2014.09.004","article-title":"Ataxia","volume":"33","author":"Akbar U","year":"2015","unstructured":"Akbar U, Ashizawa T. Ataxia. Neurol Clin. 2015, 33:225-48. 10.1016\/j.ncl.2014.09.004","journal-title":"Neurol Clin"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27121","article-title":"Consensus statement on the classification of tremors from the task force on tremor of the International Parkinson and Movement Disorder Society","volume":"33","author":"Bhatia KP","year":"2018","unstructured":"Bhatia KP, Bain P, Bajaj N, et al.. Consensus statement on the classification of tremors from the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord. 2018, 33:75-87. 10.1002\/mds.27121","journal-title":"Mov Disord"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.02.43","article-title":"Neurologic impairment in Wilson disease","volume":"7","author":"Dusek P","year":"2019","unstructured":"Dusek P, Litwin T, Cz\u0142onkowska A. Neurologic impairment in Wilson disease. Ann Transl Med. 2019, 7:S64. 10.21037\/atm.2019.02.43","journal-title":"Ann Transl Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-013-0378-8","article-title":"The pathophysiology of essential tremor and Parkinson\u2019s tremor","volume":"13","author":"Helmich RC","year":"2013","unstructured":"Helmich RC, Toni I, Deuschl G, Bloem BR. The pathophysiology of essential tremor and Parkinson\u2019s tremor. Curr Neurol Neurosci Rep. 2013, 13:378. 10.1007\/s11910-013-0378-8","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref20","article-title":"MR imaging of the brain in Wilson disease of childhood: findings before and after treatment with clinical correlation","volume":"27","author":"Kim TJ","year":"2006","unstructured":"Kim TJ, Kim IO, Kim WS, et al.. MR imaging of the brain in Wilson disease of childhood: findings before and after treatment with clinical correlation. Am J Neuroradiol. 2006, 27:1373-8.","journal-title":"Am J Neuroradiol"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.1002\/mds.25244","article-title":"The prevalence of primary dystonia: a systematic review and meta-analysis","volume":"27","author":"Steeves TD","year":"2012","unstructured":"Steeves TD, Day L, Dykeman J, et al.. The prevalence of primary dystonia: a systematic review and meta-analysis. Mov Disord. 2012, 27:1789-96.","journal-title":"Mov Disord"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.1002\/mds.1118","article-title":"Dystonia in Wilson\u2019s disease","volume":"16","author":"Svetel M","year":"2001","unstructured":"Svetel M, Kozi\u0107 D, Stefanova E, Semnic R, Draga\u0161evi\u010d N, Kosti\u010d VS. Dystonia in Wilson\u2019s disease. Mov Disord. 2001, 16:719-23.","journal-title":"Mov Disord"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-316250","article-title":"Pathogenesis of dystonia: is it of cerebellar or basal ganglia origin?","volume":"89","author":"Kaji R","year":"2018","unstructured":"Kaji R, Bhatia K, Graybiel AM. Pathogenesis of dystonia: is it of cerebellar or basal ganglia origin?. J Neurol Neurosurg Psychiatry. 2018, 89:488-92. 10.1136\/jnnp-2017-316250","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000763","article-title":"Chorea","volume":"25","author":"Termsarasab P","year":"2019","unstructured":"Termsarasab P. Chorea. Continuum (Minneap Minn). 2019, 25:1001-1035. 10.1212\/CON.0000000000000763","journal-title":"Continuum (Minneap Minn)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI14341","article-title":"Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency","volume":"109","author":"Krude H","year":"2002","unstructured":"Krude H, Sch\u00fctz B, Biebermann H, et al.. Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency. J Clin Invest. 2002, 109:475-80. 10.1172\/JCI14341","journal-title":"J Clin Invest"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-004-1047-8","article-title":"Wilson disease","volume":"445","author":"Langner C","year":"2004","unstructured":"Langner C, Denk H. Wilson disease. Virchows Arch. 2004, 445:111-118. 10.1007\/s00428-004-1047-8","journal-title":"Virchows Arch"},{"key":"ref27","article-title":"Hyperkinetic movement disorders in children: a brief review","volume":"13","author":"Nikkhah A","year":"2019","unstructured":"Nikkhah A, Karimzadeh P, Taghdiri MM, Nasehi MM, Javadzadeh M, Khari E. Hyperkinetic movement disorders in children: a brief review. Iran J Child Neurol. 2019, 13:7-16.","journal-title":"Iran J Child Neurol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1159\/000442941","article-title":"Frontal lobe degeneration in adults with Down syndrome and Alzheimer\u2019s disease: a review","volume":"41","author":"Fonseca LM","year":"2016","unstructured":"Fonseca LM, Yokomizo JE, Bottino CM, Fuentes D. Frontal lobe degeneration in adults with Down syndrome and Alzheimer\u2019s disease: a review. Dement Geriatr Cogn Disord. 2016, 41:123-36. 10.1159\/000442941","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref29","article-title":"Neuropsychological findings in treated Wilson\u2019s disease","volume":"81","author":"Lang C","year":"1990","unstructured":"Lang C, M\u00fcller D, Claus D,  Druschky KF. Neuropsychological findings in treated Wilson\u2019s disease. Acta Neurol Scand. 1990, 81:75-81.","journal-title":"Acta Neurol Scand"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1044\/2015_AJSLP-14-0113","article-title":"Be clear: a new intensive speech treatment for adults with nonprogressive dysarthria","volume":"25","author":"Stacie P","year":"2016","unstructured":"Stacie P, Theodoros D, Finch E, Cardell E. Be clear: a new intensive speech treatment for adults with nonprogressive dysarthria. Am J Speech Lang Pathol. 2016, 25:97-110. 10.1044\/2015_AJSLP-14-0113","journal-title":"Am J Speech Lang Pathol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2010.01.007","article-title":"Spectrum of epilepsy in Wilson's disease with electroencephalographic, MR imaging and pathological correlates","volume":"291","author":"Prashanth LK","year":"2010","unstructured":"Prashanth LK, Sinha S, Taly AB, A Mahadevan, Vasudev MK, Shankar SK. Spectrum of epilepsy in Wilson's disease with electroencephalographic, MR imaging and pathological correlates. J Neurol Sci. 2010, 291:44-51. 10.1016\/j.jns.2010.01.007","journal-title":"J Neurol Sci"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2018.12.005","article-title":"Predictors of seizure in Wilson disease: a clinico-radiological and biomarkers study","volume":"71","author":"Kalita J","year":"2019","unstructured":"Kalita J, Misra UK, Kumar V, Parashar V. Predictors of seizure in Wilson disease: a clinico-radiological and biomarkers study. Neurotoxicology. 2019, 71:87-92. 10.1016\/j.neuro.2018.12.005","journal-title":"Neurotoxicology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/41584-neurological-manifestations-of-wilsons-disease-pathophysiology-and-localization-of-each-component","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:20:03Z","timestamp":1707506403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/41584-neurological-manifestations-of-wilsons-disease-pathophysiology-and-localization-of-each-component"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,16]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.11509","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,16]]}}}